CARA THERAPEUTICS INC. - COMMON STOCK

Cara Therapeutics to Announce Third Quarter 2023 Financial Results on November 13, 2023

23 окт 2023 07:00:00 Источник Nasdaq GlobeNewswire

Cara Therapeutics Announces Approval of KORSUVA® IV Injection Syringe in Japan for the Treatment of Pruritus in Hemodialysis Patients

25 сен 2023 07:00:32 Источник Nasdaq GlobeNewswire

Cara Therapeutics Reports Second Quarter 2023 Financial Results

07 авг 2023 16:01:00 Источник Nasdaq GlobeNewswire

Cara Therapeutics Appoints Helen M. Boudreau to Board of Directors

03 авг 2023 07:00:00 Источник Nasdaq GlobeNewswire

Cara Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference

02 авг 2023 07:00:00 Источник Nasdaq GlobeNewswire

Cara Therapeutics to Present at the Jefferies Healthcare Conference

01 июн 2023 07:00:00 Источник Nasdaq GlobeNewswire

Kapruvia® (difelikefalin) recommended by England’s NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus

18 май 2023 02:00:00 Источник Nasdaq GlobeNewswire

Cara Therapeutics Reports First Quarter 2023 Financial Results

15 май 2023 16:01:00 Источник Nasdaq GlobeNewswire

Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023

01 май 2023 07:00:01 Источник Nasdaq GlobeNewswire

Cara Therapeutics Announces Presentation at the 22nd Annual Needham Virtual Healthcare Conference

10 апр 2023 07:00:00 Источник Nasdaq GlobeNewswire

Cara Therapeutics Releases Inaugural Environmental, Social, and Governance Report

14 мар 2023 07:00:00 Источник Nasdaq GlobeNewswire

Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results

06 мар 2023 16:01:00 Источник Nasdaq GlobeNewswire

Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023

21 фев 2023 07:00:02 Источник Nasdaq GlobeNewswire

Cara Therapeutics Announces Results from the KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Notalgia Paresthetica Published in the New England Journal of Medicine

08 фев 2023 17:00:00 Источник Nasdaq GlobeNewswire

Cara Therapeutics to Host Capital Markets Day on Thursday, February 16, 2023

17 янв 2023 07:00:00 Источник Nasdaq GlobeNewswire

Cara Therapeutics Announces Presentation at the 41st Annual J.P. Morgan Healthcare Conference

03 янв 2023 07:00:01 Источник Nasdaq GlobeNewswire

Cara Therapeutics Reports Third Quarter 2022 Financial Results

07 ноя 2022 16:01:01 Источник Nasdaq GlobeNewswire

Cara Therapeutics Announces Appointment of Lisa von Moltke, M.D., to its Board of Directors

03 ноя 2022 07:00:01 Источник Nasdaq GlobeNewswire

Cara Therapeutics to Present at Upcoming Investor Conferences

02 ноя 2022 07:00:02 Источник Nasdaq GlobeNewswire

Cara Therapeutics to Announce Third Quarter 2022 Financial Results on November 7, 2022

24 окт 2022 07:00:00 Источник Nasdaq GlobeNewswire